Cambridge Investment Research Advisors’s Bright Horizons BFAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,331
Closed -$282K 3066
2022
Q2
$282K Buy
+3,331
New +$331K ﹤0.01% 2434
2021
Q4
Sell
-1,481
Closed -$206K 3175
2021
Q3
$206K Buy
1,481
+15
+1% +$2.2K ﹤0.01% 2792
2021
Q2
$216K Sell
1,466
-4,988
-77% -$746K ﹤0.01% 2759
2021
Q1
$1.11M Buy
6,454
+397
+7% +$65.4K 0.01% 1368
2020
Q4
$1.05M Buy
6,057
+4,473
+282% +$732K 0.01% 1271
2020
Q3
$241K Sell
1,584
-604
-28% -$76K ﹤0.01% 2100
2020
Q2
$256K Buy
2,188
+167
+8% +$19.1K ﹤0.01% 2005
2020
Q1
$206K Sell
2,021
-4,350
-68% -$640K ﹤0.01% 1912
2019
Q4
$957K Sell
6,371
-115
-2% -$17.3K 0.01% 1172
2019
Q3
$989K Buy
6,486
+4,535
+232% +$709K 0.01% 1076
2019
Q2
$294K Buy
1,951
+236
+14% +$31.6K ﹤0.01% 1757
2019
Q1
$218K Sell
1,715
-301
-15% -$35.9K ﹤0.01% 2012
2018
Q4
$225K Buy
2,016
+108
+6% +$12.4K ﹤0.01% 1845
2018
Q3
$225K Buy
+1,908
New +$216K ﹤0.01% 1980

Other funds holding BFAM

Cambridge Investment Research Advisors's BFAM Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of Bright Horizons (BFAM) in Q3 2022, closing a stake of 3,331 shares — an estimated $282K sold.

Cambridge Investment Research Advisors first reported a position in BFAM in Q3 2018 and held it in 14 quarters. The position peaked at $1.11M in Q1 2021. 292 funds tracked by Wall St. Rank hold BFAM as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining Bright Horizons position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 3,331 Bright Horizons shares in Q3 2022, an estimated $282K.
  • Cambridge Investment Research Advisors first reported a position in Bright Horizons in Q3 2018 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Bright Horizons position peaked at $1.11M in Q1 2021.
  • 292 funds tracked by Wall St. Rank held Bright Horizons as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.